A.G.E. Interrupter Advanced
SkinCeuticals
Anti-aging skincare / corrective creamAnti-glycation restructuring cream (mature skin)
Certifications
- Marketed by SkinCeuticals through authorised retail and professional channels; product is a cosmetic/dermocosmetic topical formulation and is not presented as an MHRA Licensed medicinal product.
- Manufacturing and distribution follow SkinCeuticals corporate/regional regulatory and distribution practices (regional cosmetic regulatory compliance applies).
- Marketed by SkinCeuticals through authorised retail and professional channels; product is a cosmetic/dermocosmetic topical formulation and is not presented as an MHRA Licensed medicinal product.
- Manufacturing and distribution follow SkinCeuticals corporate/regional regulatory and distribution practices (regional cosmetic regulatory compliance applies).
Anti-glycation restructuring cream (mature skin)
Description
A.G.E. Interrupter Advanced is a SkinCeuticals corrective cream formulated to fight visible signs of aging caused by advanced glycation end-products (A.G.E.). Marketed for mature, crepey or thinned skin, the formulation combines concentrated proxylane (Proxylane™), a wild fruit flavonoid blend (blueberry/pomegranate extracts), glycyrrhetinic acid (soothing), hepes buffering system and niacinamide to help restore firmness, reduce the appearance of wrinkles and improve texture and comfort of dry aging skin. Pack size commonly sold: 48 ml.
Bnefits
- Targets skin damage associated with glycation to help restore firmness and elasticity.
- Improves appearance of fine lines, wrinkles and creping/texture associated with mature skin.
- Contains concentrated proxylane and a wild fruit flavonoid blend to protect against oxidative stress.
- Formulated to comfort dry, aging skin and to be used as part of an anti-aging regimen.
Indications
- Mature skin showing visible signs of aging linked to glycation (loss of firmness, creping, fine lines and wrinkles).
- Skin requiring restructuring and improved elasticity/firmness.
Composition
- INCI (as listed by SkinCeuticals / distributor sources): Aqua / Water / Eau; Propylene Glycol; Dimethicone; Hydroxypropyl Tetrahydropyrantriol (Proxylane™); Cyclohexasiloxane; Isohexadecane; Glycerin; Synthetic Wax; Dimethicone/PEG-10/15 Crosspolymer; Aluminium Starch Octenylsuccinate; CI 77163 / Bismuth Oxychloride; Phenoxyethanol; Magnesium Sulfate; Ethylhexyl Hydroxystearate; Salicyloyl Phytosphingosine; Acrylates Copolymer; Methylparaben; Ethylparaben; Disodium EDTA; Vaccinium Myrtillus Extract / Vaccinium Myrtillus Fruit Extract (blueberry); Parfum / Fragrance; Butylphenyl Methylpropional; Coumarin
- Key actives called out in marketing/product pages: Proxylane™ (concentrated proxylane, SkinCeuticals proprietary ingredient), Wild Fruit Flavonoid blend (blueberry/pomegranate extracts), Glycyrrhetinic acid (glycyrrhetinic acid / glycyrrhizin derivative), Niacinamide, HEPES buffering system, Phytosphingosine (reported in some retailer copy as 0.2% in older formula statements).
Formulation
- Rich cream / balm formulation intended for twice-daily application to face, neck and chest.
- Pack size commonly marketed as 48 ml (1.7 fl oz).
Packaging
- 48 ml jar/tube (retailer and official product pages list 48 ml presentation).
- Retail packaging and barcodes vary by region; retailers may reference internal product codes or EAN/GTINs.
Usage
- Massage a thin, even layer into the entire face, neck and chest once or twice daily (manufacturer product/regimen guidance).
- Use as part of a daily anti-aging regimen with cleansing, prevention (eg. sunscreen), corrective serums and moisturiser as appropriate (manufacturer regimen guidance).
Contraindications
- Not publicly listed
Adverse Effects
- Not publicly listed
Storage Conditions
- Not publicly listed
Duration
Not publicly listed (no fixed course duration specified; product recommended for ongoing use as part of an anti-aging regimen).
Onset
Not publicly listed (manufacturer/regulatory pages do not provide a precise onset-of-action timeline; clinical/consumer results described as improvement over continued use).
